Where does OsteoMed LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OsteoMed LLC ranks #8,455 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OsteoMed LLC hold?

OsteoMed LLC holds 38 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is OsteoMed LLC's Innovation Score?

OsteoMed LLC has an Innovation Score of 35.2 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does OsteoMed LLC focus on?

OsteoMed LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 31 patents, ranking #603 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is OsteoMed LLC's patent grant rate increasing or decreasing?

OsteoMed LLC's recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for OsteoMed LLC's patents?

OsteoMed LLC's patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OsteoMed LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

OsteoMed LLC

USPTO PatentsView assignee record - 38 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Osteomed ranks #8,455 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 6 technology areas.

#8,455
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.2/100): 13.8
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8455 · US Corporation #8,455 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 38 grants
UPPER-Q #8,455/49,997
PHOTO-FINISH National Steel Car
CPC-NARROW A61B · 6 areas
INNOV-THIN 35.2/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: National Steel Car Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Osteomed’s 35.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.7 pts (36%) Velocity 5.6 pts (16%) Breadth 8.7 pts (25%) Claim depth 8.3 pts (24%)

Qualcomm Incorporated · highest

85
Allergan Industrie SAS · near

35
Cyalume · near

35
OsteoMed · this assignee

35
Shenzhen Grandsun · near

35
Shenzhen Tize… · near

35
3D Lighting… · lowest

7

What this shows Osteomed's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Osteomed?

Each dot is one of Osteomed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Osteomed’s own 13.8 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Osteomed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Osteomed's grants concentrate

OsteoMed LLC is a focused PatentsView assignee: 6 CPC subclasses with 81.6% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (8 grants) versus a trough of 1 in 2022. By volume, Osteomed sits between National Steel Car Limited and Personalis, Inc..

Osteomed's three-year grant acceleration

OsteoMed LLC shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

National Steel Car

38
Novimmune

38
Ormat

38
Otos Wing

38
Parata Systems

38
Packers Plus Ener…

38
Palodex Group Oy

38
Personalis

38
Osteomed ◀

38

What this shows OsteoMed holds 38 patents at rank #8,456, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OsteoMed

By rank, the assignees closest to #8,456 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in OsteoMed's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OsteoMed, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), OsteoMed ranks #603 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Allergan Industrie, SAS 35 Shenzhen Grandsun Electronic Co., Ltd. 35 Shenzhen Tize Technology Co., Ltd. 35 Cyalume Technologies, Inc. 35

Osteomed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

OsteoMed LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	21.1%
2016	7	18.4%
2017	2	5.3%
2018	5	13.2%
2019	2	5.3%
2020	4	10.5%
2022	1	2.6%
2023	3	7.9%
2024	1	2.6%
2025partial year	5	13.2%

Which technologies does OsteoMed LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 31

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

B22F - Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

OsteoMed LLC's patent record in context - here's where to go next.

OsteoMed LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 81.6% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #8,455 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OsteoMed LLC against National Steel Car Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.